Evaluating the risks and benefits of electronic cigarettes for older smokers at high risk for lung cancer
The potential risks and benefits of electronic cigarettes to older smokers at high risk for lung cancer
This study is looking at whether older smokers who don’t want to quit can improve their health by switching to electronic cigarettes instead of continuing to smoke regular cigarettes, and it involves 330 participants trying out either option for six months.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11098623 on NIH RePORTER |
What this research studies
This research investigates how older smokers, who are at high risk for lung cancer and are unwilling to quit smoking, might benefit from switching to electronic cigarettes (ECs). The study will involve 330 participants who will be randomly assigned to either use ECs or continue with their usual brand of combustible cigarettes for six months. Researchers will assess changes in smoking behavior, product acceptability, nicotine dependence symptoms, and various health biomarkers to determine if ECs provide a safer alternative to traditional smoking. The goal is to understand the real-world implications of using ECs in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates are older smokers who are at high risk for lung cancer, uninterested in quitting, but willing to try electronic cigarettes.
Not a fit: Patients who are not smokers or those who are actively seeking to quit smoking may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide insights into safer smoking alternatives for older adults, potentially reducing their risk of lung cancer.
How similar studies have performed: Previous research has indicated that electronic cigarettes may be less harmful than traditional cigarettes, but this specific approach in older smokers is novel.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Robinson, Jason D — University of Tx Md Anderson Can Ctr
- Study coordinator: Robinson, Jason D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.